Request Demo
Last update 15 Aug 2026
ZX2010
Last update 15 Aug 2026
Overview
Basic Info
Drug Type Fc fusion protein |
Synonyms GGF-7, ZX2010 |
Target |
Action agonists |
Mechanism GIPR agonists(Gastric inhibitory polypeptide receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with ZX2010CTR20252333
长效GLP-1/GIP双重受体激动剂（ZX2010）注射液在中国2型糖尿病受试者中的有效性和安全性的随机、双盲、安慰剂对照Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase II clinical trial of the efficacy and safety of a long-acting GLP-1/GIP dual receptor agonist (ZX2010) injection in Chinese subjects with type 2 diabetes
CTR20241290
长效GLP-1/GIP双重受体激动剂（ZX2010）注射液在中国健康受试者中的安全性、耐受性和药代动力学的随机、双盲、安慰剂对照、单次和多次给药I期临床试验
[Translation] A randomized, double-blind, placebo-controlled, single- and multiple-dose phase I clinical trial of the safety, tolerability, and pharmacokinetics of a long-acting GLP-1/GIP dual receptor agonist (ZX2010) injection in healthy Chinese subjects
CTR20263071
评估ZX2010注射液在中国非糖尿病超重或肥胖参与者中多次皮下给药的安全性、耐受性、药代动力学和药效学的随机、双盲、安慰剂对照Ib 期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase Ib clinical trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of ZX2010 injection with multiple subcutaneous administrations in non-diabetic, overweight, or obese participants in China.
100 Clinical Results associated with ZX2010
Login to view more data
100 Translational Medicine associated with ZX2010
Login to view more data
100 Patents (Medical) associated with ZX2010
Login to view more data
100 Deals associated with ZX2010
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 2 | China | 21 Jul 2025 | |
| Obesity | Phase 1 | China | 10 May 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free